SEC Form 4 · accession 0001638727-15-000002
Lexaria Bioscience Corp. · LXRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Martin Docherty
Officer — President
Period of report
Mar 26, 2015
Accepted (ET)
May 22, 2015 · 6:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | May 15, 2015 | P | 130,000 | $0.10 | A | 130,000 | I | Private Holding Company |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $0.25 | May 15, 2015 | P | 130,000 | A | May 15, 2015 | May 15, 2017 | Common Shares | 130,000 | 130,000 | I |
| Stock Options | $0.10 | holding | — | — | — | Mar 26, 2015 | Mar 26, 2020 | Common Shares | 500,000 | 500,000 | D |